Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: EZLibra who wrote (2487)	8/29/1998 11:55:00 AM
From: Shlepper	Read Replies (1) \| Respond to of 3702

Davis, Golfdad, If the Phase 1 trials demonstrated safety (albeit on end-stage terminal cases), how will this translate to allowing patients who are in earlier stages of glioblastomas to participate in the TNT clinical trials? Conventional treatment currently prolongs longevity to a small degree with debilitating side affects. I have recommended the TNT alternative to a young lady in her 20's who has been given 3-8 years to live. She is an optimist and wants to have children, but the chemo makes that scenario unlikely. I'm a little bothered with some of the banter on YAHOO regarding daily price movements of the stock. This is all meaningless. It's the cure that matters. Anyway, ask my young lady friend... Thanks for your comments. Shlepper